University of Melbourne
University of Melbourne, Peter MacCallum Cancer Centre Launch Precision Oncology JV
The institutions aim to improve equitable access to precision oncology advances and patients' outcomes through their collaborative effort.
Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer
Researchers examined genetic, tumor mutation, and immune features among individuals surviving at least a decade after an advanced ovarian cancer diagnosis.
Researchers reported prospective randomized trial data showing non-inferiority of adjuvant treatment guided by minimal residual disease testing.
Breast, Lung Cancer Outcomes Informed by Gene Expression of Individual Infiltrating T Cells
Two new studies have uncovered expression-defined T cell subsets that seem to coincide with better or worse outcomes in breast cancer or non-small cell lung cancer.
Breast, Lung Cancer Genetics Highlight Mutations Linked to Drug Response, Prognosis
New tumor profiling papers stemming from prior clinical trials led to informative mutations in early-stage, ER+/HER2- breast cancer and lung squamous cell carcinoma.